Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MRPS18B | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | NRROS | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
mRNA | ZNF776 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | YY1AP1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | PXYLP1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | IGLL1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | DNTT | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | PLXND1 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | SAMD14 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | CEP131 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |